3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
5
Colorectal Neoplasms
4
Hematologic Neoplasms
3
Prostatic Neoplasms
2
Motor Activity
2
Lung Neoplasms
2
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Trastuzumab Cardiotoxicity
1
Stress Disorders, Post-Traumatic
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Myocardial Fibrosis
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Insulin Resistance
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Heart Diseases
1
Head and Neck Neoplasms
1
Gastrointestinal Diseases
1
Fatigue
1
Esophageal Neoplasms
1
Dyslipidemias
1
Depression
1
Interventions
Yoga
2
Therapeutics
2
Educational Status
2
Early Intervention, Educational
2
Behavior Therapy
2
exemestane
1
Zolpidem
1
Venlafaxine Hydrochloride
1
Valeriana extract
1
Uncertainty
1
Triptorelin Pamoate
1
Tamoxifen
1
Surveys and Questionnaires
1
Psychosocial Intervention
1
Psychiatric Rehabilitation
1
N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide
1
Methods
1
Melatonin
1
Hypnosis
1
Gonadotropin-Releasing Hormone
1
Exercise Test
1
Donepezil
1
Counseling
1
Cognitive Behavioral Therapy
1
Acupuncture Therapy
1
Acceptance and Commitment Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sleep Wake Disorders
×
Exercise Test
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts